PCM
JAGX icon

Perritt Capital Management’s Jaguar Health JAGX Stock Holding History

Perritt Capital Management’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$89.5K – 315
2024
Q2 		$89.5K Buy
+4
New +$199K 0.05% 200

Other funds holding JAGX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perritt Capital Management's JAGX Position: Q3 2024 in Review

Perritt Capital Management sold out of Jaguar Health (JAGX) in Q3 2024, closing a stake of 4 shares — an estimated $89.5K sold.

Perritt Capital Management first reported a position in JAGX in Q2 2024 and held it in 1 quarter. The position peaked at $89.5K in Q2 2024. 8 funds tracked by Wall St. Rank hold JAGX as of Q3 2024.

  • Perritt Capital Management reported no remaining Jaguar Health position as of Q3 2024 after selling out during the quarter.
  • Perritt Capital Management sold 4 Jaguar Health shares in Q3 2024, an estimated $89.5K.
  • Perritt Capital Management first reported a position in Jaguar Health in Q2 2024 and held it in 1 quarter.
  • Perritt Capital Management's Jaguar Health position peaked at $89.5K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held Jaguar Health as of Q3 2024.

Based on Perritt Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.